|
| 37424725 | Case report: Extending the spectrum of clinical and molecular findings in FOXC1 haploinsufficiency syndrome. | Front Genet | 2023 |
| 37992966 | GLI1-Altered Mesenchymal Tumors With ACTB or PTCH1 Fusion: A Molecular and Clinicopathologic Analysis. | | 2023 |
| 36493359 | Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series. | Oncologist | 2023 |
| 37262067 | Effectors Enabling Adaptation to Mitochondrial Complex I Loss in Hürthle Cell Carcinoma. | Cancer Discov | 2023 |
| 36812363 | Clinical Next-Generation Sequencing Panels Reveal Molecular Differences Between Merkel Cell Polyomavirus-Negative Merkel Cell Carcinomas and Neuroendocrine Carcinomas. | Am J Clin Pathol | 2023 |
| 37437230 | Longitudinal Molecular Analysis of Tumor Exome and Transcriptome to Evaluate Clonal Evolution and Identify Novel Therapeutic Targets in Thymoma. | JCO Precis Oncol | 2023 |
| 34587239 | t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity. | Blood Adv | 2022 |
| 36178347 | Primary Thyroid Neoplasm with Fetal Morphology Associated with <i>DICER1</i> Mutations: Expanding the Diagnostic Profile of Thyroblastoma. | Thyroid | 2022 |
| 35457138 | Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma. | Int J Mol Sci | 2022 |
| 35871080 | Identification of fusions with potential clinical significance in melanoma. | Mod Pathol | 2022 |
| 35852437 | Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network. | Oncologist | 2022 |
| 34074959 | Low-grade Endometrial Stromal Sarcoma With Sex Cord-like Differentiation and PHF1-JAZF1 Fusion With Deletions: A Diagnostic Pitfall of JAZF1 FISH. | International Journal of Gynecological Pathology | 2022 |
| 35274388 | American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment. | Head Neck | 2022 |
| 34571863 | Prognostic Roles of , , , and Mutations in Mucosal Melanomas. | Cells | 2021 |
| 34019236 | Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis. | Endocrine Pathology | 2021 |
| 33807452 | Merkel Cell Carcinoma of Unknown Primary: Immunohistochemical and Molecular Analyses Reveal Distinct UV-Signature/MCPyV-Negative and High Immunogenicity/MCPyV-Positive Profiles. | Cancers | 2021 |
| 33991527 | Intraductal carcinoma of the salivary gland with NCOA4-RET: expanding the morphologic spectrum and an algorithmic diagnostic approach. | Human Pathology | 2021 |
| 34091485 | Mucoacinar Carcinoma: A Rare Variant of Mucoepidermoid Carcinoma. | Am J Surg Pathol | 2021 |
| 32737449 | Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization. | Modern Pathology | 2020 |
| 31941831 | Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers. | Clin Cancer Res | 2020 |
| 32347351 | BRAF Mutation is Associated with an Increased Risk of Papillary Thyroid Cancer Recurrence. | World Journal of Surgery | 2020 |
| 32292131 | Response to RET-Specific Therapy in <i>RET</i> Fusion-Positive Anaplastic Thyroid Carcinoma. | Thyroid | 2020 |
| 32457407 | Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC). | Modern Pathology | 2020 |
| 32923872 | Pan-Cancer Landscape Analysis Reveals Recurrent <i>KMT2A</i>-<i>MAML2</i> Gene Fusion in Aggressive Histologic Subtypes of Thymoma. | JCO Precis Oncol | 2020 |
| 31430493 | Novel and established EWSR1 gene fusions and associations identified by next-generation sequencing and fluorescence in-situ hybridization. | Hum Pathol | 2019 |
| 31745334 | Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers. | Nat Med | 2019 |
| 30550363 | EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes. | J Clin Oncol | 2019 |
| 30594750 | Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms. | Hum Pathol | 2019 |
| 30130630 | Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family. | Hum Pathol | 2019 |
| 31036078 | PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma. | Acta Neuropathol Commun | 2019 |
| 30975663 | PI3K/AKT/mTOR Pathway Alterations Promote Malignant Progression and Xenograft Formation in Oligodendroglial Tumors. | Clin Cancer Res | 2019 |
| 31501609 | Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers. | Nat Med | 2019 |
| 29431697 | Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in <i>BRAF</i><sup>V600E</sup> Colorectal Cancer. | Cancer Discov | 2018 |
| 30123863 | Heterogeneity and Coexistence of T790M and T790 Wild-Type Resistant Subclones Drive Mixed Response to Third-Generation Epidermal Growth Factor Receptor Inhibitors in Lung Cancer. | JCO Precis Oncol | 2018 |
| 30257958 | Landscape of Acquired Resistance to Osimertinib in <i>EGFR</i>-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired <i>RET</i> Fusion. | Cancer Discov | 2018 |
| 30107175 | Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma. | Cancer Cell | 2018 |
| 30370396 | Clinical Utility of Rapid <i>EGFR</i> Genotyping in Advanced Lung Cancer. | JCO Precis Oncol | 2018 |
| 30364844 | Artificial Intelligence Approach for Variant Reporting. | JCO Clin Cancer Inform | 2018 |
| 29472312 | Complete Remission Following Pembrolizumab in a Woman with Mismatch Repair-Deficient Endometrial Cancer and a Germline Mutation. | Oncologist | 2018 |
| 28192645 | Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma. | Cancer cytopathology | 2017 |
| 28821194 | Primary Benign and Malignant Thyroid Neoplasms With Signet Ring Cells: Cytologic, Histologic, and Molecular Features. | American Journal of Clinical Pathology | 2017 |
| 28734009 | KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas. | British Journal of Dermatology | 2017 |
| 28780248 | Invasive follicular variant of papillary thyroid cancer harboring the NRAS mutation Q61K and presenting with bone metastasis-A case report. | International Journal of Surgery Case Reports | 2017 |
| 29872694 | Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor. | NPJ Precis Oncol | 2017 |
| 31032471 | Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer-Transformed <i>EGFR</i> Mutant Non-Small-Cell Lung Cancer. | JCO Precis Oncol | 2017 |
| 28007702 | Immunohistochemical Detection of ROS1 Fusion. | American Journal of Clinical Pathology | 2017 |
| 28293986 | Clear Cell Change in Thyroid Carcinoma: A Clinicopathologic and Molecular Study with Identification of Variable Genetic Anomalies. | Thyroid | 2017 |
| 27543214 | Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome. | Journal of the American Academy of Dermatology | 2016 |
| 27026089 | Colorectal cancer in Crohn's colitis is comparable to sporadic colorectal cancer. | Int J Colorectal Dis | 2016 |
| 27432227 | Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer. | Cancer Discov | 2016 |